Verona Pharma Correlations

VRNA Stock  USD 81.20  3.71  4.79%   
The current 90-days correlation between Verona Pharma PLC and Syndax Pharmaceuticals is 0.42 (i.e., Very weak diversification). The correlation of Verona Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Verona Pharma Correlation With Market

Very weak diversification

The correlation between Verona Pharma PLC and DJI is 0.51 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Verona Pharma PLC and DJI in the same portfolio, assuming nothing else is changed.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verona Pharma PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Moving together with Verona Stock

  0.71DRTS Alpha Tau MedicalPairCorr
  0.65VIGL Vigil NeurosciencePairCorr
  0.66VKTX Viking TherapeuticsPairCorr
  0.78VSTM VerastemPairCorr
  0.81VTYX Ventyx Biosciences Earnings Call This WeekPairCorr
  0.66EDIT Editas MedicinePairCorr

Moving against Verona Stock

  0.68DRRX DurectPairCorr
  0.43DYAI Dyadic InternationalPairCorr
  0.43KTTAW Pasithea TherapeuticsPairCorr
  0.34DVAX Dynavax TechnologiesPairCorr
  0.31VCYT VeracytePairCorr
  0.43VYNE Vyne TherapeuticsPairCorr
  0.4EDSA Edesa BiotechPairCorr
  0.4ELUT Elutia IncPairCorr
  0.36VRTX Vertex PharmaceuticalsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
DAWNSNDX
XFORDAWN
ABOSDAWN
ABOSXFOR
TERNIDYA
TERNMREO
  
High negative correlations   
INZYXFOR
INZYDAWN
INZYSNDX
ABOSINZY
MREOINZY
PTGXIDYA

Risk-Adjusted Indicators

There is a big difference between Verona Stock performing well and Verona Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Verona Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
VTYX  4.64  0.38  0.07  0.23  5.15 
 9.66 
 26.10 
IDYA  3.16  0.05  0.01  0.01  4.27 
 6.44 
 23.99 
PTGX  2.92  0.56  0.24  4.84  2.17 
 5.35 
 51.02 
SNDX  3.91 (0.40) 0.00 (0.32) 0.00 
 8.30 
 30.68 
DAWN  3.49 (0.53) 0.00 (0.48) 0.00 
 7.30 
 22.66 
XFOR  4.83 (1.69) 0.00 (1.67) 0.00 
 8.31 
 27.97 
INZY  8.28  3.26  0.53  1.46  4.37 
 10.42 
 179.17 
ABOS  3.82 (0.22) 0.00 (0.27) 0.00 
 7.84 
 25.32 
MREO  3.38 (0.07) 0.00 (0.10) 0.00 
 7.33 
 19.17 
TERN  4.11 (0.12) 0.00 (0.13) 0.00 
 7.94 
 21.70 

Verona Pharma Corporate Management

Caroline DiazSenior AffairsProfile
LCSW BAG CounselProfile
Matthew CasbonMarketing SalesProfile
Peter SpargoSenior ControlsProfile
Kathleen MDChief OfficerProfile
B ASIAGeneral CounselProfile